Promoting antihepatocellular carcinoma activity against human HepG2 cells via pyridine substituted palladium complexes: in vitro evaluation and QSAR studies.
Autor: | Meral Ö; Department of Biochemistry, Faculty of Veterinary Medicine, Ankara University, Ankara, Turkey., Emen FM; Department of Chemistry, Faculty of Arts and Sciences, Burdur Mehmet Akif Ersoy University, Burdur, Turkey., Kutlu E; Department of Chemistry, Faculty of Arts and Sciences, Burdur Mehmet Akif Ersoy University, Burdur, Turkey., Demirdöğen RE; Department of Chemistry, Faculty of Science, Çankırı Karatekin University, Çankırı, Turkey., Kaya Kinaytürk N; Department of Nanoscience and Nanotechnology, Faculty of Arts and Sciences, Burdur Mehmet Akif Ersoy University, Burdur, Turkey., Kismali G; Department of Biochemistry, Faculty of Veterinary Medicine, Ankara University, Ankara, Turkey., Doğan Ş; Department of Nursing, Faculty of Health Sciences, Burdur Mehmet Akif Ersoy University, Burdur, Turkey. |
---|---|
Jazyk: | angličtina |
Zdroj: | Turkish journal of chemistry [Turk J Chem] 2023 Jan 04; Vol. 47 (1), pp. 280-293. Date of Electronic Publication: 2023 Jan 04 (Print Publication: 2023). |
DOI: | 10.55730/1300-0527.3536 |
Abstrakt: | Bis(4-(4-nitrobenzyl)pyridine)dichloropalladium(II), [PdCl Competing Interests: Conflict of interest The authors declare no conflict of interest. (© TÜBİTAK.) |
Databáze: | MEDLINE |
Externí odkaz: |